2m 2m 2m 2m 2m 2m 2m
CARDIFF ONCOLOGY (CRDF)
NASDAQ
$0.91+$0.02 (+2.83%)
Price as of Aug 21, 2026 7:44 PM EDT- $68.5MMarket Cap
- -62.06%1-Year Change
- BiotechnologyIndustry
CARDIFF ONCOLOGY (CRDF)
$0.91+$0.02 (+2.83%)
CRDF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.88 | ||
Change | -$0.03 (-3.15%) | ||
Open | $0.93 | ||
High | $0.93 | ||
Low | $0.88 | ||
Previous Close | $0.91 | ||
Volume | 653,486 | ||
30-Day Average Volume | 824,489 | ||
1-Week Change | -8.61% | ||
1-Month Change | 4.77% | ||
1-Year Change | -62.06% | ||
3-Year Change | -51.38% | ||
5-Year Change | -83.97% | ||
Fundamentals | |||
Shares Outstanding | 77.8M | ||
Total Assets | $37.3M | ||
Market Cap | $68.5M | ||
Enterprise Value | $59.3M | ||
Period: QTR TTM FY | |||
Revenue | $104,000.00 | ||
Net Income | -$9.2M | ||
Free Cash Flow | -$11.8M | ||
EBIT | -$9.2M | ||
EBITDA | -$9.1M | ||
Net Working Capital | $24.8M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 570 | ||
P/B | 3 | ||
P/E | -6 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 02/20/2019 | ||
Earnings & Revenue